Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?

被引：255

作者：

Apetoh, L. ^{[1
,2
,3
]}

Ladoire, S. ^{[1
,2
,3
]}

Coukos, G. ^{[4
]}

Ghiringhelli, F. ^{[1
,2
,3
]}

机构：

[1] INSERM, U866, Lipids Nutr Canc, Dijon, France

[2] Univ Bourgogne, Dept Med, Dijon, France

[3] Ctr Georges Francois Leclerc, Dept Oncol, Dijon, France

[4] Univ Lausanne, Dept Oncol, Lausanne, Switzerland

来源：

ANNALS OF ONCOLOGY | 2015年 / 26卷 / 09期

关键词：

chemotherapy; radiotherapy; anticancer immunity; immunomodulation; CD4 T cells; CD8 T cells; REGULATORY T-CELLS; METASTATIC BREAST-CARCINOMA; C-RECEPTOR POLYMORPHISMS; VIVO ANTITUMOR-ACTIVITY; NATURAL-KILLER-CELLS; DE-NOVO MALIGNANCY; TUMOR-CELLS; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; SUPPRESSOR-CELLS;

D O I：

10.1093/annonc/mdv209

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Recent clinical trials revealed the impressive efficacy of immunological checkpoint blockade in different types of metastatic cancers. Such data underscore that immunotherapy is one of the most promising strategies for cancer treatment. In addition, preclinical studies provide evidence that some cytotoxic drugs have the ability to stimulate the immune system, resulting in anti-tumor immune responses that contribute to clinical efficacy of these agents. These observations raise the hypothesis that the next step for cancer treatment is the combination of cytotoxic agents and immunotherapies. The present review aims to summarize the immune-mediated effects of chemotherapeutic agents and their clinical relevance, the biological and clinical features of immune checkpoint blockers and finally, the preclinical and clinical rationale for novel therapeutic strategies combining anticancer agents and immune checkpoint blockers.

引用

页码：1813 / 1823

页数：11

共 166 条

[61]

Paclitaxel and immune system [J].

Javeed, Aqeel ;

Ashraf, Muhammad ;

Riaz, Amjad ;

Ghafoor, Aamir ;

Afzal, Sheryar ;

Mukhtar, Muhammad Mahmood .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (04) :283-290

[62]

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells [J].

Kaech, SM ;

Tan, JT ;

Wherry, EJ ;

Konieczny, BT ;

Surh, CD ;

Ahmed, R .

NATURE IMMUNOLOGY, 2003, 4 (12) :1191-1198

[63]

Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology [J].

Kalos, Michael ;

June, Carl H. .

IMMUNITY, 2013, 39 (01) :49-60

[64]

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia [J].

Kalos, Michael ;

Levine, Bruce L. ;

Porter, David L. ;

Katz, Sharyn ;

Grupp, Stephan A. ;

Bagg, Adam ;

June, Carl H. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (95)

[65]

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer [J].

Kershaw, Michael H. ;

Westwood, Jennifer A. ;

Parker, Linda L. ;

Wang, Gang ;

Eshhar, Zelig ;

Mavroukakis, Sharon A. ;

White, Donald E. ;

Wunderlich, John R. ;

Canevari, Silvana ;

Rogers-Freezer, Linda ;

Chen, Clara C. ;

Yang, James C. ;

Rosenberg, Steven A. ;

Hwu, Patrick .

CLINICAL CANCER RESEARCH, 2006, 12 (20) :6106-6115

[66]

Immunotherapy of cancer in 2012 [J].

Kirkwood, John M. ;

Butterfield, Lisa H. ;

Tarhini, Ahmad A. ;

Zarour, Hassane ;

Kalinski, Pawel ;

Ferrone, Soldano .

CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (05) :309-335

[67]

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells [J].

Klebanoff, CA ;

Finkelstein, SE ;

Surman, DR ;

Lichtman, MK ;

Gattinoni, L ;

Theoret, MR ;

Grewal, N ;

Spiess, PJ ;

Antony, PA ;

Palmer, DC ;

Tagaya, Y ;

Rosenberg, SA ;

Waldmann, TA ;

Restifo, NP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (07) :1969-1974

[68]

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model [J].

Ko, Hyun-Jeong ;

Kim, Yeon-Jeong ;

Kim, Yun-Sun ;

Chang, Woo-Sung ;

Ko, Sung-Youl ;

Chang, Sun-Young ;

Sakaguchi, Shimon ;

Kang, Chang-Yuil .

CANCER RESEARCH, 2007, 67 (15) :7477-7486

[69]

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients [J].

Ko, Jennifer S. ;

Zea, Arnold H. ;

Rin, Brian I. ;

Ireland, Joanna L. ;

Elson, Paul ;

Cohen, Peter ;

Golshayan, Ali ;

Rayman, Patricia A. ;

Wood, Laura ;

Garcia, Jorge ;

Dreicer, Robert ;

Bukowski, Ronald ;

Finke, James H. .

CLINICAL CANCER RESEARCH, 2009, 15 (06) :2148-2157

[70]

RETRACTED: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019) [J].

Kohrt, Holbrook E. ;

Houot, Roch ;

Weiskopf, Kipp ;

Goldstein, Matthew J. ;

Scheeren, Ferenc ;

Czerwinski, Debra ;

Colevas, A. Dimitrios ;

Weng, Wen-Kai ;

Clarke, Michael F. ;

Carlson, Robert W. ;

Stockdale, Frank E. ;

Mollick, Joseph A. ;

Chen, Lieping ;

Levy, Ronald .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (03) :1066-1075

← 2 3 4 5 6 7 8 9 10 11 →